• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病:最新进展与未来展望。

Alzheimer's disease: recent advances and future perspectives.

机构信息

Department of Neurosciences, University of California, San Diego, CA 92093-0624, USA.

出版信息

J Alzheimers Dis. 2013;33 Suppl 1:S185-94. doi: 10.3233/JAD-2012-129028.

DOI:10.3233/JAD-2012-129028
PMID:22810100
Abstract

Alzheimer's disease (AD) is an age-related neurodegenerative disorder characterized by progressive memory deficits and other cognitive disturbances. Neuropathologically, AD is characterized by the progressive loss of basal forebrain cholinergic neurons that innervate the hippocampus and cortex and the abnormal extracellular accumulation of amyloid-β and intracellular tau protein. Current research on AD is focused on the mechanisms underlying the abnormal oligomerization, fibrillation, and accumulation of the amyloid-β and tau proteins, mechanisms that may alter the dynamics of this accumulation and on experimental therapeutics approaches aimed at the clearance of the abnormally folded proteins and other potentially neuroprotective interventions. This review will summarize the main areas of investigation in AD and present ways forward for future work.

摘要

阿尔茨海默病(AD)是一种与年龄相关的神经退行性疾病,其特征是进行性记忆障碍和其他认知障碍。神经病理学上,AD 的特征是基底前脑胆碱能神经元逐渐丧失,这些神经元支配海马体和大脑皮层,以及异常的淀粉样β和细胞内 tau 蛋白的细胞外积累。目前对 AD 的研究集中在淀粉样β和 tau 蛋白异常寡聚、纤维化和积累的机制上,这些机制可能改变这种积累的动态,并探讨实验治疗方法,旨在清除异常折叠的蛋白质和其他潜在的神经保护干预措施。这篇综述将总结 AD 的主要研究领域,并为未来的工作提出方向。

相似文献

1
Alzheimer's disease: recent advances and future perspectives.阿尔茨海默病:最新进展与未来展望。
J Alzheimers Dis. 2013;33 Suppl 1:S185-94. doi: 10.3233/JAD-2012-129028.
2
Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.阿尔茨海默病与基底前脑胆碱能系统:与β-淀粉样肽、认知及治疗策略的关系
Prog Neurobiol. 2002 Oct;68(3):209-45. doi: 10.1016/s0301-0082(02)00079-5.
3
Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer's Disease.自噬的分子机制:其在阿尔茨海默病治疗中的作用
Curr Neuropharmacol. 2020;18(8):720-739. doi: 10.2174/1570159X18666200114163636.
4
Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.淀粉样β和磷酸化 tau 诱导的阿尔茨海默病中的自噬和 mitophagy 缺陷。
Cells. 2019 May 22;8(5):488. doi: 10.3390/cells8050488.
5
Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease.β-淀粉样蛋白与中枢胆碱能神经元之间的相互作用:对阿尔茨海默病的影响。
J Psychiatry Neurosci. 2004 Nov;29(6):427-41.
6
Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.淀粉样蛋白级联假说:阿尔茨海默病的发病机制与治疗策略
Neuropeptides. 2015 Aug;52:1-18. doi: 10.1016/j.npep.2015.06.008. Epub 2015 Jul 2.
7
The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.衰老及阿尔茨海默病期间大脑中胆碱能系统的意义。
J Neural Transm (Vienna). 2006 Nov;113(11):1625-44. doi: 10.1007/s00702-006-0579-2. Epub 2006 Oct 13.
8
[beta-Amyloid, cholinergic neurons and Alzheimer's disease].[β-淀粉样蛋白、胆碱能神经元与阿尔茨海默病]
Cesk Fysiol. 2002 May;51(2):82-94.
9
Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches.阿尔茨海默病:对初始 Tau 细胞骨架病理学脑区的特征描述将提高新型免疫抗 Tau 治疗方法的成功率。
J Alzheimers Dis. 2017;57(3):683-696. doi: 10.3233/JAD-161102.
10
Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer's disease.用于阿尔茨海默病的新兴治疗药物及药物重新利用的最新进展。
Ageing Res Rev. 2023 Mar;85:101815. doi: 10.1016/j.arr.2022.101815. Epub 2022 Dec 16.

引用本文的文献

1
Causal association between gastrointestinal diseases and coronary artery disease: a bidirectional Mendelian randomization study.胃肠道疾病与冠状动脉疾病之间的因果关系:一项双向孟德尔随机化研究。
Front Endocrinol (Lausanne). 2024 Oct 15;15:1458196. doi: 10.3389/fendo.2024.1458196. eCollection 2024.
2
A review: effects of neurofeedback on patients with mild cognitive impairment (MCI), and Alzheimer's disease (AD).综述:神经反馈对轻度认知障碍(MCI)患者及阿尔茨海默病(AD)患者的影响。
Front Hum Neurosci. 2024 Feb 14;17:1331436. doi: 10.3389/fnhum.2023.1331436. eCollection 2023.
3
Discoveries and future significance of research into amyloid-beta/α7-containing nicotinic acetylcholine receptor (nAChR) interactions.
发现并探讨淀粉样β/α7 包含型烟碱型乙酰胆碱受体(nAChR)相互作用的未来意义。
Pharmacol Res. 2023 May;191:106743. doi: 10.1016/j.phrs.2023.106743. Epub 2023 Apr 20.
4
Amentoflavone Promotes Cellular Uptake and Degradation of Amyloid-Beta in Neuronal Cells.山奈酚黄酮促进神经元细胞中淀粉样β肽的细胞摄取和降解。
Int J Mol Sci. 2022 May 24;23(11):5885. doi: 10.3390/ijms23115885.
5
Design, synthesis, and evaluation of 8-aminoquinoline-melatonin derivatives as effective multifunctional agents for Alzheimer's disease.8-氨基喹啉-褪黑素衍生物作为阿尔茨海默病有效多功能药物的设计、合成与评价
Ann Transl Med. 2022 Mar;10(6):303. doi: 10.21037/atm-22-730.
6
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects.GLP-1 受体激动剂:超越其胰腺作用。
Front Endocrinol (Lausanne). 2021 Aug 23;12:721135. doi: 10.3389/fendo.2021.721135. eCollection 2021.
7
Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine.预测、预防和个性化(3P)医学框架下的内皮素-1轴
EPMA J. 2021 Aug 4;12(3):265-305. doi: 10.1007/s13167-021-00248-z. eCollection 2021 Sep.
8
Syringin Prevents Aβ-Induced Neurotoxicity in SK-N-SH and SK-N-BE Cells by Modulating miR-124-3p/BID Pathway.橙皮苷通过调节 miR-124-3p/BID 通路来预防 Aβ诱导的 SK-N-SH 和 SK-N-BE 细胞神经毒性。
Neurochem Res. 2021 Mar;46(3):675-685. doi: 10.1007/s11064-021-03240-1. Epub 2021 Jan 20.
9
Benign Regulation of the Astrocytic Phospholipase A-Arachidonic Acid Pathway: The Underlying Mechanism of the Beneficial Effects of Manual Acupuncture on CBF.星形胶质细胞磷脂酶A-花生四烯酸途径的良性调节:手动针刺对脑血流量有益作用的潜在机制。
Front Neurosci. 2020 Feb 4;13:1354. doi: 10.3389/fnins.2019.01354. eCollection 2019.
10
Polyphenolic Biflavonoids Inhibit Amyloid-Beta Fibrillation and Disaggregate Preformed Amyloid-Beta Fibrils.多酚类双黄酮抑制β-淀粉样蛋白的纤维化并分解预先形成的β-淀粉样蛋白纤维。
Biomol Ther (Seoul). 2020 Mar 1;28(2):145-151. doi: 10.4062/biomolther.2019.113.